Calyxin B exhibits significant potential in pharmaceutical research due to its biological activity. It has demonstrated anti-inflammatory and neuroprotective properties, making it a candidate for development in treatments targeting neurodegenerative conditions such as Alzheimer’s disease. Studies suggest it may modulate key signaling pathways involved in oxidative stress and neuronal damage. Additionally, Calyxin B shows inhibitory effects against certain cancer cell lines, indicating possible utility in oncology for supporting cytotoxic activity in tumor cells. Its natural origin and structural features also make it a useful scaffold in designing derivatives for drug discovery. Research is ongoing to explore its bioavailability and therapeutic efficacy in preclinical models.